RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
215 hedge funds and large institutions have $2.07B invested in Revance Therapeutics, Inc. in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 86 increasing their positions, 60 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less funds holding
Funds holding: 216 → 215 (-1)
16% less capital invested
Capital invested by funds: $2.46B → $2.07B (-$389M)
Holders
215
Holding in Top 10
3
Calls
$36.5M
Puts
$20.2M
Top Buyers
| 1 | +$38.7M | |
| 2 | +$31M | |
| 3 | +$25.7M | |
| 4 |
DM
Deerfield Management
New York
|
+$22M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.1M |
Top Sellers
| 1 | -$46.3M | |
| 2 | -$14.1M | |
| 3 | -$12.7M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$11.9M |
| 5 |
Two Sigma Advisers
New York
|
-$10.8M |